Nitric Oxide
Nitric Oxide is a pharmaceutical drug with 70 clinical trials. Currently 5 active trials ongoing. Historical success rate of 78.4%.
Success Metrics
Based on 40 completed trials
Phase Distribution
Phase Distribution
18
Early Stage
30
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
40 of 56 finished
28.6%
16 ended early
5
trials recruiting
70
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.
Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients
Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients
Effects of Nitric Oxide on the Endothelium During Hemolysis.
Clinical Trials (70)
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.
Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients
Effects of Prolonged Delivery of Nitric Oxide Gas on Plasma Reduction-Oxidation Reactions in Cardiac Surgical Patients
Effects of Nitric Oxide on the Endothelium During Hemolysis.
Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection
Diffuse Optical Monitoring With Inhaled Nitric Oxide
NO During CPB in Neonates to Reduce Risk of AKI
Vascular ARDS Recruitment After Inhaled Nitric Oxide
Inhaled Nitric Oxide in Severe Obesity
Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance
Nitric Oxide, GeNO Nitrosyl Delivery System
The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
The Effect of Inhaled Nitric Oxide on Maximal Oxygen Consumption During Exercise in Hypoxia
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study
Nitric Oxide During Bypass for Arterial Switch Operation
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)
Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).
The Effect of Inhaled Nitric Oxide on Deadspace in COPD
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 70